Cite

    Ningombam, A. et al. (2022). Addition of oral fexofenadine to topical therapy leads to a significantly greater reduction in the serum interleukin‐31 levels in mild to moderate paediatric atopic dermatitis. Clinical and experimental dermatology. pp. 724-729. [Online].